Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy

被引:63
作者
Dustin, L. B. [1 ]
Bartolini, B. [2 ]
Capobianchi, M. R. [2 ]
Pistello, M. [3 ,4 ,5 ]
机构
[1] Univ Oxford, Kennedy Inst Rheumatol & Peter Medawar Bldg Patho, Oxford, England
[2] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Virol Lab, Rome, Italy
[3] Univ Pisa, Virol Unit, Pisa Univ Hosp, Pisa, Italy
[4] Univ Pisa, Virol Sect, Pisa, Italy
[5] Univ Pisa, Retrovirus Ctr, Dept Translat Res, Pisa, Italy
关键词
Broadly reactive neutralizing antibodies; Cell culture-derived HCV; Direct antiviral agents; Drug resistance; Genotype; Hepatitis C virus; Host response monitoring drug resistance; Pathogenesis; Quantitative molecular assays; IMMUNE-RESPONSES; HCV INFECTION; CLINICAL UTILITY; NATURAL-HISTORY; INNATE IMMUNITY; GLOBAL-CONTROL; RNA; RESISTANCE; QUANTIFICATION; PERFORMANCE;
D O I
10.1016/j.cmi.2016.08.025
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Hepatitis C virus (HCV) is a major global health burden accounting for around 170 million chronic infections worldwide. Since its discovery, which dates back to about 30 years ago, many details of the viral genome organization and the astonishing genetic diversity have been unveiled but, owing to the difficulty of culturing HCV in vitro and obtaining fully susceptible yet immunocompetent in vivo models, we are still a long way from the full comprehension of viral life cycle, host cell pathways facilitating or counteracting infection, pathogenetic mechanisms in vivo, and host defences. Here, we illustrate the viral life cycle into cells, describe the interplay between immune and genetic host factors shaping the course of infection, and provide details of the molecular approaches currently used to genotype, monitor replication in vivo, and study the emergence of drug-resistant viral variants. (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:826 / 832
页数:7
相关论文
共 91 条
[61]   Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy [J].
Sarrazin, Christoph ;
Wedemeyer, Heiner ;
Cloherty, Gavin ;
Cohen, Daniel E. ;
Chevaliez, Stephane ;
Herman, Christine ;
Bernstein, Barry ;
Pawlotsky, Jean Michel .
JOURNAL OF VIROLOGICAL METHODS, 2015, 214 :29-32
[62]   Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection [J].
Sarrazin, Christoph ;
Zeuzem, Stefan .
GASTROENTEROLOGY, 2010, 138 (02) :447-462
[63]   Performance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or Serum [J].
Schalasta, Gunnar ;
Speicher, Andrea ;
Boerner, Anna ;
Enders, Martin .
JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (04) :1101-1107
[64]   Innate Immune Responses to Hepatitis C Virus [J].
Schoggins, John W. ;
Rice, Charles M. .
HEPATITIS C VIRUS: FROM MOLECULAR VIROLOGY TO ANTIVIRAL THERAPY, 2013, 369 :219-242
[65]   Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness [J].
Sheahan, Timothy ;
Imanaka, Naoko ;
Marukian, Svetlana ;
Dorner, Marcus ;
Liu, Peng ;
Ploss, Alexander ;
Rice, Charles M. .
CELL HOST & MICROBE, 2014, 15 (02) :190-202
[66]   The Origin of Hepatitis C Virus [J].
Simmonds, Peter .
HEPATITIS C VIRUS: FROM MOLECULAR VIROLOGY TO ANTIVIRAL THERAPY, 2013, 369 :1-15
[67]   Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource [J].
Smith, Donald B. ;
Bukh, Jens ;
Kuiken, Carla ;
Muerhoff, A. Scott ;
Rice, Charles M. ;
Stapleton, Jack T. ;
Simmonds, Peter .
HEPATOLOGY, 2014, 59 (01) :318-327
[68]   Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles [J].
Steinmann, Eike ;
Brohm, Christiane ;
Kallis, Stephanie ;
Bartenschlager, Ralf ;
Pietschmann, Thomas .
JOURNAL OF VIROLOGY, 2008, 82 (14) :7034-7046
[69]   Real-Time PCR Assays for the Quantification of HCV RNA: Concordance, Discrepancies and Implications for Response Guided Therapy [J].
Strassl, Robert ;
Rutter, Karoline ;
Staettermayer, Albert Friedrich ;
Beinhardt, Sandra ;
Kammer, Michael ;
Hofer, Harald ;
Ferenci, Peter ;
Popow-Kraupp, Theresia .
PLOS ONE, 2015, 10 (08)
[70]   Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection [J].
Sulkowski, Mark S. ;
Gardiner, David F. ;
Rodriguez-Torres, Maribel ;
Reddy, K. Rajender ;
Hassanein, Tarek ;
Jacobson, Ira ;
Lawitz, Eric ;
Lok, Anna S. ;
Hinestrosa, Federico ;
Thuluvath, Paul J. ;
Schwartz, Howard ;
Nelson, David R. ;
Everson, Gregory T. ;
Eley, Timothy ;
Wind-Rotolo, Megan ;
Huang, Shu-Pang ;
Gao, Min ;
Hernandez, Dennis ;
McPhee, Fiona ;
Sherman, Diane ;
Hindes, Robert ;
Symonds, William ;
Pasquinelli, Claudio ;
Grasela, Dennis M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (03) :211-221